Sam Cooper is a Co-Founder of Phenomic AI, holding an educational background in Biochemistry and Life Sciences. His company pioneers the use of AI for drug discovery and development, employing advanced deep learning algorithms to predict the binding affinity between small molecules and proteins. This approach facilitates the identification of potential drug candidates for various diseases.